Resource Library
All resources
Filter By

Telecom Case study
See the outcomes of a large telecom company that executed responsible GLP-1 management and metabolic control through their partnership with Vida.

The case for a new standard in metabolic health measurement
For decades, body mass index (BMI) has served as the shorthand for defining obesity and, by extension, metabolic health…

The Viewpoint from Vida: where does AI fit into healthcare?
AI in telehealth must be governed by the principle of “do no harm” and must serve, not shape, care. AI improves care by reducing clinical workflow friction and streamlining data among other benefits however, when it comes to healthcare where do we have a responsibility to be sure humans are calling the shots?

CapRx Case Study
See the outcomes of a coordinated solution that pairs Vida’s personalized care with Judi® -driven medication management promoting behavior change and appropriate use of GLP-1s.

The Employer’s Guide to GLP-1 Coverage Strategy
GLP-1 medications have changed the conversation about metabolic care. It has also created a delicate balancing act between cost and accessibility for employers.

The Consultant’s Guide to GLP-1 Coverage Strategy
GLP-1 medications have changed the conversation about metabolic care. It has also created a delicate balancing act between cost and accessibility for employers, and the consultants who guide them.

The Viewpoint from Vida: what happens after GLP-1s?
Whether or not someone continues GLP-1 therapy is a clinical decision that should be made in partnership with their healthcare provider. But what are the strategic benefits, and what are the risks?

7 Reasons Employers and Health Plans Need to Get Ahead of MASH Costs
MASH isn’t a new problem, it’s a newly visible one. As obesity and diabetes continue to drive healthcare costs, metabolic liver disease is emerging as a critical missing piece in many employer strategies.

MASH: The hidden driver of rising costs and cardiometabolic risk
MASH is one of the fastest-growing and most overlooked drivers of metabolic risk and rising healthcare costs.

Making GLP-1s Work: Rethinking Access and Affordability
For plan sponsors, the decisions made today will shape costs, outcomes, and member trust for years to come. A smarter strategy blends access, affordability, and clinical excellence rather than forcing tradeoffs.

Expanding access to obesity care: Breaking the cost barrier through innovative benefit design
Watch the on-demand webinar that takes a deep dive into how organizations can respond to GLP-1 demand even when the medications aren’t covered on their formulary.

Dr. Kelly Henkler on Compassionate Obesity Care, Real Support, and the Future of Healthspan
At Vida, we know our medical team is at the heart of everything we do. In this new series, we’re spotlighting the physicians, dietitians, and coaches who bring their expertise and compassion to every member interaction. Each profile highlights their unique journeys, the impact they’ve made helping members manage chronic conditions, and the knowledge they bring to advancing evidence-based care.